10 Set-It-and-Forget-It Stocks to Buy Right Now

Page 3 of 3

6. Amgen Inc. (NASDAQ:AMGN)

Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy right now. On June 12, Piper Sandler reaffirmed its Overweight rating and $427 price target for Amgen Inc. (NASDAQ:AMGN). The firm published a detailed review of the Sjogren’s syndrome therapeutic development environment in advance of Amgen’s CD40 ligand-directed fusion protein dazodalibep’s Phase III conclusion in the latter half of 2026.

Amgen Inc. (NASDAQ:AMGN) is conducting research in two distinct Sjogren’s categories: moderate-to-severe symptoms-related burden with low systemic disease progression and moderate-to-severe systemic disease activity.

According to Piper Sandler, dazodalibep is a comparatively underappreciated part of Amgen’s growing immunology/inflammation pharmaceutical line.

In a similar vein, Morgan Stanley maintained its Overweight rating on Amgen Inc. (NASDAQ:AMGN) while increasing its price objective to $340 from $332 on June 9. The firm pointed out that Amgen’s portfolio of cutting-edge medications is bolstered by the company’s recent acquisition of Horizon.

According to Morgan Stanley, the stock’s future depends on pipeline development, with a major focus on MariTide against obesity.

Amgen Inc. (NASDAQ:AMGN) is a drug manufacturer that delivers human therapeutics through pharmaceutical wholesale distributors. The company was founded in 1980 and is headquartered in California.

While we acknowledge the potential of AMGN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMGN and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Set-It-and-Forget-It Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.

Page 3 of 3
1281292 - 11759070 - 1